Michael R. Foley - Jan 28, 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
Chief Medical Officer
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Stock symbol
SERA
Transactions as of
Jan 28, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 05:06 PM
Previous filing
Jan 4, 2022
Next filing
Mar 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Award $0 +276K $0.00 276K Jan 28, 2022 Class A Common Stock 276K $6.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is January 28, 2022, and 1/36 of the remaining amount vests in monthly installments for three years thereafter.